Oligonucleotide Synthesis Market
Oligonucleotide Synthesis Market Study by Reagents & Consumables, Equipment, and Synthesized Oligonucleotides for Research, Therapeutics, and Diagnostics from 2024 to 2034
Analysis of Oligonucleotide Synthesis Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Oligonucleotide Synthesis Market Outlook (2024 to 2034)
The global oligonucleotide synthesis market size is approximated at US$ 6.76 billion in 2024 and is foreseen to expand at a CAGR of 10.9% to reach US$ 19.01 billion by the end of 2034.
Increasing FDA approvals for oligonucleotides as therapeutic agents, a robust R&D pipeline of pharmaceutical and biotechnology companies, and a rise in clinical trials for new diseases are some of the factors driving the oligonucleotide synthesis market growth. The lifestyle changes are contributing to increasing cases related to genetic disorders further driving demand for oligonucleotide synthesis.
Several leading companies are investing in R&D to develop novel oligonucleotides. Oligonucleotide is a combination of nucleotides, each containing a phosphate group, sugar molecule (ribose in RNA and deoxyribose in DNA), and any one nitrogenous (thymine (T) in DNA, cytosine (C), adenine (A), guanine (G), or uracil (U) in RNA). The growing popularity of molecular diagnostic is an emerging oligonucleotide synthesis market trend.
- Making a step forward in the field of targeted RNA medicines, researchers from Novo Nordisk and Aarhus University in 2023 discovered a new method for synthesis of oligonucleotide conjugates.
The presence of robust healthcare facilities, rising prevalence of genetic disorders, and rising investments in R&D are fuelling the market growth in North America.
- North America is expected to hold 34.4% of the oligonucleotide synthesis market share by 2034.
- The East Asian oligonucleotide synthesis market size is evaluated at US$ 1.17 billion in 2024.
Expanding healthcare sector, rising awareness of genetic disorders, and key market players focus on building plants in the region due to supportive policies is expected to drive the growth of the oligonucleotide synthesis market in East Asia.
| Report Attributes | Details |
|---|---|
| Oligonucleotide Synthesis Market Size (2024E) | US$ 6.76 Billion |
| Forecasted Market Value (2034F) | US$ 19.01 Billion |
| Global Market Growth Rate (2024 to 2034) | 10.9% CAGR |
| South Korea Market Value (2034F) | US$ 795.3 Million |
| Key Companies Profiled | Kaneka Eurogentec S.A.; TriLink Biotechnologies LLC; BioAutomation; Danaher Corporation; Dharmacon Inc.; Thermo Fisher Scientific Corporation; GE Healthcare; ATDBio Ltd.; Twist Bioscience; Merck KGaA; Integrated DNA Technologies Inc.; Sigma-Aldrich Corporation; Agilent Technologies; LGC Biosearch Technologies |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Dynamics are Driving Demand for Oligonucleotide Synthesis Solutions?
“Path-breaking Developments in Synthetic Chemistry Boosting Demand for Oligonucleotide Synthesis”
Oligonucleotides are primarily used in biological and forensic applications in research, disease diagnosis, and therapeutics. Natural oligonucleotides have been extensively used for the selection and determination of the DNA sequences such as hybridization probes or affinity purification, gene construction, and site-directed mutagenesis. In addition, they are used to inhibit gene expression in in-vitro studies for diagnostic purposes.
Rising usage of oligonucleotides is augmenting the need for technological developments in synthetic chemistry. Several biotechnology and pharmaceutical companies are thus engaged in the development of newer and advanced methods.
- Integrated DNA Technologies recently developed oligonucleotides up to 200 base lengths which are used with mass spectrometry for manufacturing mini-genes.
Which Obstacles are Lowering Profits of Oligonucleotide Synthesis Companies?
“High Costs and Complexity of Oligonucleotide Synthesis”
Significance of synthetic oligonucleotides as therapeutic drugs for treating diseases has full-fledged significantly in the last decade. Though, there have been numerous instances in the past, wherein owing to high complications such as high cost & severe side effects, countless drugs have been inhibited or have been abortive in clinical trial phases. Such instances could become recurring and may restrict market growth to a certain extent. Furthermore complexity of oligonucleotide synthesis may also hamper the overall market growth.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Is Oligonucleotide Synthesis a Profitable Market for New Companies?
“Focus on Research and Development Efforts to Develop Effective Oligonucleotide Synthesis Products”
Gene and cell therapies often struggle due to off-target effects. This may be due to engineered organisms interact unintended targets. Also, in the real world environment scalability of synthetic constructs is major concern. To address such concerns advanced gene editing tools such as (Clustered Regularly Interspaced Short Palindromic Repeats) CRISPR Systems are expected to be more effective.
New companies should invest in research and development activities to introduce advanced oligonucleotide synthesis technology. This move would aid them to cater to a wider consumer base and earn high profits.
- Graphite Bio a United States based start-up has developed an UltraHDR platform based on CRISPR technology to utilize the full potential of gene editing for precise DNA repair.
- Cardior a German start-up offers a non-coding RNA therapeutics for heart condition patients. The company is using an AAV (Adeno-associated Viruses) to deliver a synthetic ncRNA inhibitor to restore cardiac function and lower aberrant expression. The gene therapies that utilize oligonucleotides are expected to offer promising results in reversing such conditions.
Country-wise Analysis
According to Fact.MR, a market research and competitive intelligence provider, the United States is estimated to hold 87.5% of the North American market share in 2024. This can be driven by the presence of leading biotech companies in the country.
How is the United States Oligonucleotide Synthesis Market Evolving?
“Hefty Investments in R&D to Drive Demand for Advanced Oligonucleotide Synthesis”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 2.16 Billion |
| Growth Rate (2024 to 2034) | 12.7% CAGR |
| Projected Value (2034F) | US$ 7.15 Billion |
The United States hold a supreme position in the North American market. The fast-growing life science industry, greater focus on genetics and genomics in research and diagnostic applications, and increasing demand for high-quality oligonucleotides are attributed as key growth drivers.
Pharmaceutical companies concentrating on oligonucleotides as therapeutic agents such as antisense and RNAi therapeutics are increasing in the region. These companies are making hefty investments in molecular diagnostics and clinical applications for developing new drugs and vaccines for children and prevention of HIV/AIDS which requires extensive research, thereby fostering the demand for oligonucleotide synthesis.
Why are Oligonucleotide Synthesis Providers Venturing into South Korea?
“Upsurge in Life Science Research Projects to Boost Adoption of Oligonucleotide Synthesis”
| Attribute | South Korea |
|---|---|
| Market Value (2024E) | US$ 269 Million |
| Growth Rate (2024 to 2034) | 11.4% CAGR |
| Projected Value (2034F) | US$ 795.3 Million |
South Korea market is expected to expand at a high pace in East Asia during the forecast period, owing to its emergence as the most promising life science research hub. An increase in life science research & development and a rise in government initiatives, grants, funds, and dedicated research commercial zones are attracting domestic and foreign market players to invest in the South Korea market.
Oligonucleotides have enormous latent applications in curing an extensive array of medical conditions. They allow the expansion of therapeutics as the crashing genes to be targeted, manipulated, silenced, and/or modulated.
Will Demand for Oligonucleotide Synthesis Increase in Germany?
“Wider Earning Scope for Oligonucleotide Synthesis Producers”
German companies are focusing on the production of more efficient and greener oligonucleotide synthesis chemistry. Oligonucleotides are gaining traction in various applications such as research, therapeutics, drug discover, forensic, and agriculture. Oligonucleotides are also experiencing increasing use in forensic and biological applications as sequence-specific binding agents in Germany.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Analysis
Apart from research oligonucleotide synthesis are finding applications in therapeutics. The standing of synthetic oligos as therapeutic drugs for nursing diseases has grown remarkably in the last decade. A few of the crucial drivers for this growth are the classification of more targets following the recognition of the human genome, progressions in antisense oligos, and the expansion of double-stranded siRNA oligos.
Therapeutic oligos are also beneficial in treating diseases ranging from viral infections, respiratory diseases, cancer, and rare diseases such as Duchenne Muscular Dystrophy (DMD), cystic fibrosis, and thrombotic thrombocytopenic purpura. Therapeutic oligonucleotides such as antisense oligonucleotides and nucleic acid aptamers are the two major types of therapies available in the market.
What is a Key Application Area of Oligonucleotide Synthesis?
“Major Use of Oligonucleotide Synthesis in Research Activities”
| Attribute | Research |
|---|---|
| Segment Value (2024E) | US$ 2.68 Billion |
| Growth Rate (2024 to 2034) | 11.7% CAGR |
| Projected Value (2034F) | US$ 8.09 Billion |
Research is emerging as a key application area, attributing to the potential of using oligonucleotide synthesis in polymerase chain reactions (PCR) and next-generation sequencing. The rising demand for drug development and discovery is anticipated to provide impetus to market growth.
Furthermore, ongoing improvements such as the induction of high throughput synthesizers, better coupling reagents, enhanced polymer supports, novel sets of protecting groups for exocyclic amino groups of nucleic bases, and the introduction of universal polymer supports are completely transforming the whole field of nucleic acids chemistry. A huge number of oligos are generally used in several research technologies such as PCR, qPCR/RT qPCR, gene synthesis, sequencing, and SNP analysis.
Which are Prime Products of Oligonucleotide Synthesis?
“Reagents & Consumables Exhibiting Increasing Application in Oligosynthesis at Lab Scale or Production Levels”
| Attribute | Reagents & Consumables |
|---|---|
| Segment Value (2024E) | US$ 3.43 Billion |
| Growth Rate (2024 to 2034) | 11.1% CAGR |
| Projected Value (2034F) | US$ 9.86 Billion |
Reagents & consumables are set to hold major global market share by 2034. Solvents and reagents play important role in DNA and RNA synthesis. Effective reagents & consumables for oligonucleotide synthesis help to reduce particulate contamination. Thus, reagents & consumables are witnessing increasing demand in pharmacogenomics, therapeutics, diagnostics, and drug discovery applications.
Competitive Landscape
Key players in the oligonucleotide synthesis market are reliant on partnerships, collaborations, acquisitions, and new software launches to stay afloat. Constant innovations to ensure a seamless client-customer relationship are the main focus of prominent market players.
- In January 2021, Thermo Fisher Scientific Inc. and Groupe Novasep SAS (Novasep) announced that Thermo Fisher completed the acquisition of Henogen S.A., Novasep’s viral vector manufacturing business for approximately 725 Million Euros in cash in Belgium.
Key Segments of Oligonucleotide Synthesis Market Research
-
By Product :
- Reagents & Consumables
- Equipment
- Synthesized Oligonucleotides
- DNA Oligonucleotides
- RNA Oligonucleotides
-
By Application :
- Research
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing
- Others
- Therapeutics
- Antisense Oligonucleotides
- Nucleic Acid Aptamers
- Diagnostics
- Research
-
By End User :
- Biotechnology & Pharmaceutical Companies
- Research Institutes
- Diagnostic Laboratories
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Key Success Factors
- 6. Global Market Value Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 7. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Product
- 7.1. Reagents & Consumables
- 7.2. Equipment
- 7.3. Synthesized oligonucleotides
- 7.3.1. DNA oligonucleotides
- 7.3.2. RNA oligonucleotides
- 7.3.3. Others
- 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Application
- 8.1. Research
- 8.1.1. Polymerase Chain Reaction
- 8.1.2. Next Generation Sequencing
- 8.1.3. Others
- 8.2. Therapeutics
- 8.2.1. Antisense Oligonucleotides
- 8.2.2. Nucleic Acid Aptamers
- 8.3. Diagnostics
- 8.1. Research
- 9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
- 9.1. Biotechnology & Pharmaceutical Companies
- 9.2. Research Institutes
- 9.3. Diagnostic Laboratories
- 10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Europe
- 10.4. Asia Pacific
- 10.5. Middle East and Africa (MEA)
- 11. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 12. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 13. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. Asia Pacific Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. GE Healthcare
- 17.2. Thermo Fisher Scientific
- 17.3. Agilent Technologies, Inc.
- 17.4. Merck KGaA
- 17.5. Integrated DNA Technologies, Inc.
- 17.6. Kaneka Eurogentec S.A. (Kaneka Corporation)
- 17.7. TriLink BioTechnologies, LLC (Maravai Life Sciences)
- 17.8. BioAutomation
- 17.9. ATDBio Ltd
- 17.10. Gene Design, Inc.
- 17.11. Eurofins Genomics
- 17.12. Other Prominent Players
- 18. Assumptions and Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Product, 2018 to 23
Table 02: Global Market Value (US$ Mn) Analysis, by Product, 2024 to 34
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2018 to 23
Table 04: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 34
Table 05: Global Market Value (US$ Mn) Analysis, by Application, 2018 to 23
Table 06: Global Market Value (US$ Mn) Analysis, by Application, 2024 to 34
Table 07: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2018 to 23
Table 08: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 34
Table 09: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 23
Table 10: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 34
Table 11: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2018 to 23
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 34
Table 13: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 23
Table 14: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 34
Table 15: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2018 to 23
Table 16: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 34
Table 17: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 23
Table 18: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 34
Table 19: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2018 to 23
Table 20: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 34
Table 21: North America Market Value (US$ Mn) Analysis, by Product, 2018 to 23
Table 22: North America Market Value (US$ Mn) Analysis, by Product, 2024 to 34
Table 23: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2018 to 23
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 34
Table 25: North America Market Value (US$ Mn) Analysis, by Application, 2018 to 23
Table 26: North America Market Value (US$ Mn) Analysis, by Application, 2024 to 34
Table 27: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2018 to 23
Table 28: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 34
Table 29: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 23
Table 30: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 34
Table 31: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2018 to 23
Table 32: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 34
Table 33: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 23
Table 34: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 34
Table 35: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2018 to 23
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 34
Table 37: Latin America Market Value (US$ Mn) Analysis, by Product, 2018 to 23
Table 38: Latin America Market Value (US$ Mn) Analysis, by Product, 2024 to 34
Table 39: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2018 to 23
Table 40: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 34
Table 41: Latin America Market Value (US$ Mn) Analysis, by Application, 2018 to 23
Table 42: Latin America Market Value (US$ Mn) Analysis, by Application, 2024 to 34
Table 43: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2018 to 23
Table 44: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 34
Table 45: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 23
Table 46: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 34
Table 47: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2018 to 23
Table 48: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 34
Table 49: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 23
Table 50: Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 34
Table 51: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2018 to 23
Table 52: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 34
Table 53: Europe Market Value (US$ Mn) Analysis, by Product, 2018 to 23
Table 54: Europe Market Value (US$ Mn) Analysis, by Product, 2024 to 34
Table 55: Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2018 to 23
Table 56: Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 34
Table 57: Europe Market Value (US$ Mn) Analysis, by Application, 2018 to 23
Table 58: Europe Market Value (US$ Mn) Analysis, by Application, 2024 to 34
Table 59: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2018 to 23
Table 60: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 34
Table 61: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 23
Table 62: Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 34
Table 63: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2018 to 23
Table 64: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 34
Table 65: Asia Pacific Market Value (US$ Mn) Analysis, by Country, 2018 to 23
Table 66: Asia Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 34
Table 67: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2018 to 23
Table 68: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 34
Table 69: Asia Pacific Market Value (US$ Mn) Analysis, by Product, 2018 to 23
Table 70: Asia Pacific Market Value (US$ Mn) Analysis, by Product, 2024 to 34
Table 71: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Product, 2018 to 23
Table 72: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 34
Table 73: Asia Pacific Market Value (US$ Mn) Analysis, by Application, 2018 to 23
Table 74: Asia Pacific Market Value (US$ Mn) Analysis, by Application, 2024 to 34
Table 75: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Application, 2018 to 23
Table 76: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 34
Table 77: Asia Pacific Market Value (US$ Mn) Analysis, by End User, 2018 to 23
Table 78: Asia Pacific Market Value (US$ Mn) Analysis, by End User, 2024 to 34
Table 79: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by End User, 2018 to 23
Table 80: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 34
Table 81: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 23
Table 82: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 34
Table 83: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2018 to 23
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 34
Table 85: MEA Market Value (US$ Mn) Analysis, by Product, 2018 to 23
Table 86: MEA Market Value (US$ Mn) Analysis, by Product, 2024 to 34
Table 87: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2018 to 23
Table 88: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 34
Table 89: MEA Market Value (US$ Mn) Analysis, by Application, 2018 to 23
Table 90: MEA Market Value (US$ Mn) Analysis, by Application, 2024 to 34
Table 91: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2018 to 23
Table 92: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 34
Table 93: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 23
Table 94: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 34
Table 95: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2018 to 23
Table 96: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 34
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 23
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 34
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 34
Figure 04: Global Market Incremental $ Opportunity, 2024 to 34
Figure 05: Global Market Share and BPS Analysis by Product, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Product, 2024 to 34
Figure 07: Global Market Attractiveness Analysis by Product, 2024 to 34
Figure 08: Global Market Value (US$ Mn) and Forecast by Reagents & Consumables, 2018 to 34
Figure 09: Global Market Incremental $ Opportunity by Reagents & Consumables, 2024 to 34
Figure 10: Global Market Value (US$ Mn) and Forecast by Equipment, 2018 to 34
Figure 11: Global Market Incremental $ Opportunity by Equipment, 2024 to 34
Figure 12: Global Market Value (US$ Mn) and Forecast by Synthesized oligonucleotides, 2018 to 34
Figure 13: Global Market Incremental $ Opportunity by Synthesized oligonucleotides, 2024 to 34
Figure 14: Global Market Share and BPS Analysis by Synthesized oligonucleotides, 2024 & 2034
Figure 15: Global Market Attractiveness Analysis by Synthesized oligonucleotides, 2024 to 34
Figure 16: Global Market Share and BPS Analysis by Application, 2024 & 2034
Figure 17: Global Market Y-o-Y Growth Projections by Application, 2024 to 34
Figure 18: Global Market Attractiveness Analysis by Application, 2024 to 34
Figure 19: Global Market Value (US$ Mn) and Forecast by Research, 2018 to 34
Figure 20: Global Market Incremental $ Opportunity by Research, 2024 to 34
Figure 21: Global Market Share and BPS Analysis by Research, 2024 & 2034
Figure 22: Global Market Attractiveness Analysis by Research, 2024 to 34
Figure 23: Global Market Value (US$ Mn) and Forecast by Therapeutics, 2018 to 34
Figure 24: Global Market Incremental $ Opportunity by Therapeutics, 2024 to 34
Figure 25: Global Market Share and BPS Analysis by Therapeutics, 2024 & 2034
Figure 26: Global Market Attractiveness Analysis by Therapeutics, 2024 to 34
Figure 27: Global Market Value (US$ Mn) and Forecast by Diagnostics, 2018 to 34
Figure 28: Global Market Incremental $ Opportunity by Diagnostics, 2024 to 34
Figure 29: Global Market Share and BPS Analysis by Application, 2024 & 2034
Figure 30: Global Market Y-o-Y Growth Projections by Application, 2024 to 34
Figure 31: Global Market Attractiveness Analysis by Application, 2024 to 34
Figure 32: Global Market Value (US$ Mn) and Forecast by Biotechnology & Pharmaceutical Companies, 2018 to 34
Figure 33: Global Market Incremental $ Opportunity by Biotechnology & Pharmaceutical Companies, 2024 to 34
Figure 34: Global Market Value (US$ Mn) and Forecast by Research Institutes, 2018 to 34
Figure 35: Global Market Incremental $ Opportunity by Research Institutes, 2024 to 34
Figure 36: Global Market Value (US$ Mn) and Forecast by Diagnostic Laboratories, 2018 to 34
Figure 37: Global Market Incremental $ Opportunity by Diagnostic Laboratories, 2024 to 34
Figure 38: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 39: Global Market Y-o-Y Growth Projections by Region, 2024 to 34
Figure 40: Global Market Attractiveness Analysis by Region, 2024 to 34
Figure 41: North America Market Share and BPS Analysis by Country, 2024 & 2034
Figure 42: North America Market Y-o-Y Growth Projections by Country, 2024 to 34
Figure 43: North America Market Attractiveness Analysis by Country, 2024 to 34
Figure 44: North America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 45: North America Market Y-o-Y Growth Projections by Product, 2024 to 34
Figure 46: North America Market Attractiveness Analysis by Product, 2024 to 34
Figure 47: North America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 48: North America Market Y-o-Y Growth Projections by Application, 2024 to 34
Figure 49: North America Market Attractiveness Analysis by Application, 2024 to 34
Figure 50: North America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 51: North America Market Y-o-Y Growth Projections by End User, 2024 to 34
Figure 52: North America Market Attractiveness Analysis by End User, 2024 to 34
Figure 53: Latin America Market Share and BPS Analysis by Country, 2024 & 2034
Figure 54: Latin America Market Y-o-Y Growth Projections by Country, 2024 to 34
Figure 55: Latin America Market Attractiveness Analysis by Country, 2024 to 34
Figure 56: Latin America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 57: Latin America Market Y-o-Y Growth Projections by Product, 2024 to 34
Figure 58: Latin America Market Attractiveness Analysis by Product, 2024 to 34
Figure 59: Latin America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 60: Latin America Market Y-o-Y Growth Projections by Application, 2024 to 34
Figure 61: Latin America Market Attractiveness Analysis by Application, 2024 to 34
Figure 62: Latin America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 63: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 34
Figure 64: Latin America Market Attractiveness Analysis by End User, 2024 to 34
Figure 65: Europe Market Share and BPS Analysis by Country, 2024 & 2034
Figure 66: Europe Market Y-o-Y Growth Projections by Country, 2024 to 34
Figure 67: Europe Market Attractiveness Analysis by Country, 2024 to 34
Figure 68: Europe Market Share and BPS Analysis by Product, 2024 & 2034
Figure 69: Europe Market Y-o-Y Growth Projections by Product, 2024 to 34
Figure 70: Europe Market Attractiveness Analysis by Product, 2024 to 34
Figure 71: Europe Market Share and BPS Analysis by Application, 2024 & 2034
Figure 72: Europe Market Y-o-Y Growth Projections by Application, 2024 to 34
Figure 73: Europe Market Attractiveness Analysis by Application, 2024 to 34
Figure 74: Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 75: Europe Market Y-o-Y Growth Projections by End User, 2024 to 34
Figure 76: Europe Market Attractiveness Analysis by End User, 2024 to 34
Figure 77: Asia Pacific Market Share and BPS Analysis by Country, 2024 & 2034
Figure 78: Asia Pacific Market Y-o-Y Growth Projections by Country, 2024 to 34
Figure 79: Asia Pacific Market Attractiveness Analysis by Country, 2024 to 34
Figure 80: Asia Pacific Market Share and BPS Analysis by Product, 2024 & 2034
Figure 81: Asia Pacific Market Y-o-Y Growth Projections by Product, 2024 to 34
Figure 82: Asia Pacific Market Attractiveness Analysis by Product, 2024 to 34
Figure 83: Asia Pacific Market Share and BPS Analysis by Application, 2024 & 2034
Figure 84: Asia Pacific Market Y-o-Y Growth Projections by Application, 2024 to 34
Figure 85: Asia Pacific Market Attractiveness Analysis by Application, 2024 to 34
Figure 86: Asia Pacific Market Share and BPS Analysis by End User, 2024 & 2034
Figure 87: Asia Pacific Market Y-o-Y Growth Projections by End User, 2024 to 34
Figure 88: Asia Pacific Market Attractiveness Analysis by End User, 2024 to 34
Figure 89: MEA Market Share and BPS Analysis by Country, 2024 & 2034
Figure 90: MEA Market Y-o-Y Growth Projections by Country, 2024 to 34
Figure 91: MEA Market Attractiveness Analysis by Country, 2024 to 34
Figure 92: MEA Market Share and BPS Analysis by Product, 2024 & 2034
Figure 93: MEA Market Y-o-Y Growth Projections by Product, 2024 to 34
Figure 94: MEA Market Attractiveness Analysis by Product, 2024 to 34
Figure 95: MEA Market Share and BPS Analysis by Application, 2024 & 2034
Figure 96: MEA Market Y-o-Y Growth Projections by Application, 2024 to 34
Figure 97: MEA Market Attractiveness Analysis by Application, 2024 to 34
Figure 98: MEA Market Share and BPS Analysis by End User, 2024 & 2034
Figure 99: MEA Market Y-o-Y Growth Projections by End User, 2024 to 34
Figure 100: MEA Market Attractiveness Analysis by End User, 2024 to 34
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is oligonucleotide synthesis market size in 2024?
The global oligonucleotide synthesis market is calculated at US$ 6.76 billion for 2024.
What are the projected sales for oligonucleotide synthesis by 2034?
The market for oligonucleotide synthesis is forecasted to reach US$ 19.01 billion by 2034.
How big is the CAGR of the oligonucleotide synthesis market?
The global market is set to register a CAGR of 10.9% through 2034.
What are the raw materials for oligonucleotide synthesis?
In the context of oligonucleotide synthesis, raw materials used are called ucleoside phosphoramidites.
Who are leading end users of oligonucleotide synthesis?
Biotechnology & pharmaceutical companies are forecasted to hold 50.3% of the global market share by 2034.
Who are the key oligonucleotide synthesis companies in the market?
Leading producers include Thermo Fisher Scientific Corporation, Integrated DNA Technologies Inc., Sigma-Aldrich Corporation, and GE Healthcare.
Oligonucleotide Synthesis Market